nutri-phite magnum s flydende middel
manglende oplysninger - uspecificeret - flydende middel - 0 g/l uspecificeret
retsevmo
eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastiske midler - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.
tagrisso
astrazeneca ab - osimertinib mesilate - carcinom, ikke-småcellet lunge - andre antineoplastiske midler, protein kinase hæmmere - tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations- the first-line treatment of adult patients nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc. tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations. - the first-line treatment of adult patients with locally advanced or metastatic nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc.
budesonid "orifarm" 3 mg enterokapsler, h?rde
orifarm a/s - budesonid - enterokapsler, hårde - 3 mg
cydectin triclamox 5+200 mg/ml pour-on, opløsning
zoetis finland oy - moxidectin, triclabendazol - pour-on, opløsning - 5+200 mg/ml - kvæg
gablofen 0,05 mg/ml injektions-/infusionsvæske, opløsning, fyldt injektionssprøjte
piramal critical care b.v. - baclofen - injektions-/infusionsvæske, opløsning, fyldt injektionssprøjte - 0,05 mg/ml
gablofen 0,5 mg/ml injektions-/infusionsvæske, opløsning, fyldt injektionssprøjte
piramal critical care b.v. - baclofen - injektions-/infusionsvæske, opløsning, fyldt injektionssprøjte - 0,5 mg/ml
gablofen 2 mg/ml injektions-/infusionsvæske, opløsning, fyldt injektionssprøjte
piramal critical care b.v. - baclofen - injektions-/infusionsvæske, opløsning, fyldt injektionssprøjte - 2 mg/ml
genotropin 12 mg pulver og solvens til injektionsvæske, opløsning
pfizer aps - somatropin, human biosyntetisk - pulver og solvens til injektionsvæske, opløsning - 12 mg
genotropin 5 mg pulver og solvens til injektionsvæske, opløsning
pfizer aps - somatropin - pulver og solvens til injektionsvæske, opløsning - 5 mg